BB vs BBIO
BlackBerry Ltd (BB) versus BridgeBio Pharma Inc (BBIO) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
BridgeBio Pharma Inc (BBIO) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported BBIO revenue for 2024-12-31 was $221.9M. Net income was -$543.3M. Revenue was up 2285.3% from 2023-12-31 to 2024-12-31. BBIO currently screens at market cap $13.24B.
BB currently screens at market cap $6.14B and trailing P/E 116.5. BBIO currently screens at market cap $13.24B.
Not investment advice. Open the BB and BBIO stock pages for the full models.
Not investment advice.